Achieve Life Sciences (ACHV) Treasury Shares (2012 - 2026)

Achieve Life Sciences has disclosed Treasury Shares across 15 years of filings, most recently posting $1.1 million for Q1 2026.

• Quarterly Treasury Shares fell 60.66% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 60.66% YoY) and the FY2025 annual result came in at $1.1 million, down 15.53% from the prior year.
• Treasury Shares steadied at $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
• Over five years, Treasury Shares peaked at $2.8 million in Q1 2025 and troughed at $252875.0 in Q4 2022.
• A 5-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares jumped 374.88% — and 2026, when it plunged 60.66%.
• Tracing ACHV's Treasury Shares over 5 years: stood at $252875.0 in 2022, then surged by 100.84% to $507875.0 in 2023, then soared by 152.77% to $1.3 million in 2024, then slipped by 15.53% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
• Business Quant data shows ACHV's Treasury Shares at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.